Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or second androgen receptor-directed therapy \[ARDT\]).
Sponsor: Amgen
Check if you qualify for this prostate cancer clinical trial in Chicago, IL
If you're searching for prostate cancer treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.